Selection of modalities, prescription, and technical issues in children on peritoneal dialysis

Area of Science:

• Nephrology
• Pediatric Dialysis
• Renal Replacement Therapy

Background:

• Automated peritoneal dialysis (APD) is a preferred method for treating pediatric uremia due to reduced patient and family burden compared to continuous ambulatory PD.
• APD provides flexible treatment options, enabling individualized prescriptions based on patient-specific factors.

Purpose of the Study:

• To highlight the importance of personalized prescription in automated peritoneal dialysis for pediatric patients.
• To discuss the assessment and monitoring of peritoneal membrane transport capacity in children undergoing PD.

Main Methods:

• Individualized APD prescription tailored to age, body size, residual renal function, and metabolic needs.
• Standardized peritoneal function tests for assessing and monitoring peritoneal membrane transport.
• Optimizing fill volume based on body surface area and clinical tolerance.
• Utilizing biocompatible and ultrafiltration-capable PD solutions, including novel pH-neutral, glucose-free options.
• Employing kinetic modeling software for precise PD prescription tailoring.

Main Results:

• APD allows for a wide range of treatment regimens, adaptable to individual pediatric patient requirements.
• Regular monitoring of peritoneal membrane transport and appropriate fill volume adjustments are crucial for maximizing dialysis efficiency.
• Newer APD machines offer enhanced programming, delivery control, and tele-dialysis capabilities, improving treatment delivery and management.

Conclusions:

• Personalized prescription, informed by peritoneal function tests and advanced technology, is key to optimizing automated peritoneal dialysis outcomes in children.
• The use of biocompatible solutions and kinetic modeling further refines APD therapy for pediatric patients with kidney failure.